Sutro Biopharma, Inc.: Form 8-K, filed Jun 14, 2023
Filed with the SEC on Jun 14, 2023 and accepted by EDGAR at Jun 14, 2023, 16:31 ET.
Items reported
- Item 1.02 Termination of a material agreement
- Item 5.07 Shareholder vote results
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0000950170-23-027975. Last ingested by Listed: Oct 24, 2026, 15:12 ET. Listed shows no prices and gives no investment advice.